by sagarp4412@gmail.com | Sep 10, 2026 | AI
An AI strategy roadmap turns scattered AI experiments into a sequenced plan tied to business outcomes: which use cases to fund first, what data and governance need to exist before scaling, and how build, buy, and partner decisions get made. At Perceptive Analytics, we...
by sagarp4412@gmail.com | Sep 10, 2026 | AI
AI chatbot cost and timeline are driven mainly by data complexity, integrations, and security needs – not the choice of AI model. Off-the-shelf platforms work fine for FAQ or lead-capture bots. Chatbots that need private data, live systems, or workflow actions...
by sagarp4412@gmail.com | Sep 10, 2026 | BI, Business Model
“Why analytics gets more expensive as you grow, and how to break that link before the next renewal”EXECUTIVE SUMMARYBills rise because no one decided how cost should behave as you grow, who owns the truth, and where meaning lives. When a platform raised prices after...
by sagarp4412@gmail.com | Aug 14, 2026 | Articles
A CXO Briefing for Life Sciences LeadershipClinical trial costs have become the defining constraint in pharmaceutical R&D economics. Phase III conduct alone now runs $55,716 per day according to Tufts CSDD’s 2024 analysis, based on budget data from 409...
by sagarp4412@gmail.com | Aug 14, 2026 | Articles
A CXO Briefing for Life Sciences LeadershipSAS has been the statistical computing backbone of pharmaceutical development for four decades. It underpins clinical trial programming, regulatory submissions, commercial analytics, and pharmacovigilance workflows across...
Recent Comments